Warm Versus Conventional 2% Lignocaine for IANB Efficacy
Recruiting
Phase 2
Interventional Study
Success of Inferior Alveolar Nerve Block
Inferior Alveolar Nerve Block
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 50
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Armed Forces Institute of Dentistry, Pakistan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study compares the anesthetic efficacy of warm versus conventional 2% lignocaine for inferior alveolar nerve block in mandibular molars, evaluating success rates and onset time.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Permanent teeth with acutely inflamed pulp without swelling or draining sinus.
* Patient who have carious mandibular molars.
* Patients of either gender aged between 18-50 years old.
* Systemically healthy patients.
* Patients who agree to attend for recall appointments and pr…
Contacts